Atlas Trials

Study to Evaluate the Response to and Safety of an 8-Day Course of Phenoptin™ Treatment in Subjects With Phenylketonuria

Clinical trial NCT00104260 · COMPLETED

Trial details

NCT number
NCT00104260
Sponsor
BioMarin Pharmaceutical
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Phenylketonurias
Start date
2004-12-01
Enrollment
700

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.